Cargando…
Downregulation of GLUT3 impairs STYK1/NOK-mediated metabolic reprogramming and proliferation in NIH-3T3 cells
Serine threonine tyrosine kinase 1 (STYK1)/novel oncogene with kinase domain (NOK) has been demonstrated to promote cell carcinogenesis and tumorigenesis, as well as to strengthen cellular aerobic glycolysis, which is considered to be a defining hallmark of cancer. As the carriers of glucose into ce...
Autores principales: | Shi, Weiye, Fu, Yu, Wang, Yingze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138895/ https://www.ncbi.nlm.nih.gov/pubmed/34055092 http://dx.doi.org/10.3892/ol.2021.12788 |
Ejemplares similares
-
Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
por: Chen, Peng, et al.
Publicado: (2014) -
STYK1/NOK affects cell cycle late mitosis and directly interacts with anaphase-promoting complex activator CDH1
por: Zeng, Su-Lin, et al.
Publicado: (2022) -
Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer
por: Huang, Zhao, et al.
Publicado: (2019) -
STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling
por: Lai, Yuanyang, et al.
Publicado: (2021) -
Jorden går (nok) ikke under alligevel
Publicado: (2008)